drugset / Trial / NCT03768609
A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults
RandomizedCrossoverOpen-labelOther
Summary
The purpose of this study is to evaluate the effect of a single oral dose of cyclosporine on the pharmacokinetics of a single oral dose of pimodivir when coadministered to healthy adult participants under fasted conditions.
Timeline
- Start
- 2018-12-06
- Primary completion
- 2019-03-06
- Completion
- 2019-03-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 400 mg | — |
| Subject | Pimodivir | Small molecule | 600 mg | Oral |
Indications
No indication recorded.